Therapeutic area
  • Enabling technologies

What the technology does

A novel functional structure of the HIV-1 capsid, which is key to infectivity, has been identified. The technology is a package of tools and data that provide an ideal position for first-in-class HIV therapeutic development.

Advantage

An entirely novel therapeutic approach to HIV treatment supported by detailed structural information, assay systems amenable to high-throughput screening and prototype blocking compounds with nM affinity.

Main application field

HIV therapy

Usage

Therapeutic development

Status

Platform for discovery

Intellectual Property

International phase PCT application, with a priority date of 20/05/2016 (PCT application number PCT/EP2017/062179)

Offering

Collaborative development and exclusive or non-exclusive licence

Key Contact

  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email support@thewebkitchen.co.uk.
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
  • We would love to send you information about LifeArc news and events. Please let us know if you would like us to contact you by selecting one of the following options:
All Licensing Opportunities